Loading clinical trials…
Loading clinical trials…
Clinical trials · failure tracking
Oncology studies whose overall status is TERMINATED, WITHDRAWN or SUSPENDED on ClinicalTrials.gov, with the stop reason exactly as the registrant posted it. A category is attached only when an explicit keyword rule matches the text; CancerIndex never infers why a study stopped.
12,383 stopped studies mapped to Malignant Neoplasm and descendants · 89% state a reason
Over the 12,383 studies matching the cancer, status and year filters (the category filter does not change this chart). Each study is counted once, in the first matching category; greyed bars are studies whose text matched no rule or was empty.
Computedrules ci-stop-reasons-v1 · keyword matching only
A category is assigned when one of its keywords appears in the posted text (case-insensitive, whole words). Rules are tested in this order and the first match wins; every match is kept in the API (reasonMatches).
| NCT | Title | Phase | Status | First posted | Lead sponsor | Why stopped (as posted) | Category |
|---|---|---|---|---|---|---|---|
| NCT00176761 | Tumor-Pulsed Dendritic Cells Used as a Tumor Vaccine | Phase 2 | terminated | Sep 15, 2005 | University of Michigan Rogel Cancer Center | not stated | Not stated |
| NCT00180830 | Glivec Phase II Pediatric Study | Phase 2 | terminated | Sep 16, 2005 | Gustave Roussy, Cancer Campus, Grand Paris | not stated | Not stated |
| NCT00180895 | Rituximab in Children and Adolescents With Relapsed and Refractory B-Cell NHL/L3ALL | Phase 2 | terminated | Sep 16, 2005 | Gustave Roussy, Cancer Campus, Grand Paris | not stated | Not stated |
| NCT00355212 | Comparison Between Radiofrequency Versus Ethanol Injection for the Treatment of… | Phase 3 | terminated | Jul 21, 2006 | Azienda Ospedaliera San Giovanni Battista | not stated | Not stated |
| NCT00337506 | Velcade Combined With High-Dose Dexamethasone in Patients With Newly Diagnosed Multiple… | Phase 2 | terminated | Jun 16, 2006 | Nantes University Hospital | not stated | Not stated |
| NCT00114946 | A Study to Compare Two Avastin-Based Treatment Regimens for the Treatment of Metastatic… | Phase 4 | terminated | Jun 21, 2005 | Genentech, Inc. | not stated | Not stated |
| NCT00209703 | Feasibility Study of mFOLFOX6 in Patients With Advanced Colorectal Cancer | Phase 2 | terminated | Sep 21, 2005 | Hokkaido Gastrointestinal Cancer Study Group | not stated | Not stated |
| NCT00179725 | Phase I/II Open-Label, Dose Escalation Study To Determine The Maximum Tolerated Dose And… | Phase 1 / Phase 2 | terminated | Sep 16, 2005 | Celgene Corporation | not stated | Not stated |
| NCT00303407 | Prophylaxis of Venous Thrombo-Embolism in Cancer Patients Under Palliative Care | — | terminated | Mar 16, 2006 | University Hospital, Geneva | not stated | Not stated |
| NCT00101621 | Pilot Study to Evaluate the Safety and Analgesic Activity of M40403 Co-Administered With… | Phase 2 | terminated | Jan 13, 2005 | MetaPhore Pharmaceuticals | not stated | Not stated |
| NCT00100737 | Comparing Interleukin-2 (IL-2) Combined With Rituximab (Rituxan) to Rituximab Alone in… | Phase 2 | terminated | Jan 7, 2005 | Chiron Corporation | not stated | Not stated |
| NCT00103428 | Intravenous CG7870 in Combination With Docetaxel in Patients With Metastatic… | Phase 1 / Phase 2 | terminated | Feb 9, 2005 | Cell Genesys | not stated | Not stated |
| NCT00209664 | Phase II Study of Oral S-1 Plus Irinotecan in Patients With Advanced Gastric Cancer | Phase 2 | suspended | Sep 21, 2005 | Hokkaido Gastrointestinal Cancer Study Group | not stated | Not stated |
| NCT00151645 | Efficacy of Activated Lymphocytes in Renal Cell Carcinoma. | Phase 2 | terminated | Sep 9, 2005 | Rennes University Hospital | not stated | Not stated |
| NCT00219765 | Safety and Efficacy of Imatinib in Combination With High Dose Chemotherapy for Acute… | Phase 1 / Phase 2 | terminated | Sep 22, 2005 | Poitiers University Hospital | not stated | Not stated |
| NCT00179738 | A Multicenter, Single-Arm, Open-Label, Study to Evaluate the Safety and Efficacy of… | Phase 2 | terminated | Sep 16, 2005 | Celgene Corporation | not stated | Not stated |
| NCT00179699 | Phase I Open-Label, Dose Escalation Study To Determine The Maximum Tolerated Dose And To… | Phase 1 | terminated | Sep 16, 2005 | Celgene Corporation | not stated | Not stated |
| NCT00179751 | A Phase I/II Study of Lenalidomide in Combination With Gemcitabine in Patients With… | Phase 1 / Phase 2 | terminated | Sep 16, 2005 | Celgene Corporation | not stated | Not stated |
| NCT00211952 | Adjuvant Celecoxib in Completely Resected pN1-2 NSCLC Patients | Phase 3 | suspended | Sep 21, 2005 | Medical University of Gdansk | not stated | Not stated |
| NCT00189371 | Reinduction Chemotherapy Containing Carboplatin and Paclitaxel With or Without Epoetin… | Phase 3 | terminated | Sep 19, 2005 | AGO Study Group | not stated | Not stated |
| NCT00162695 | Rhabdomyosarcoma and Malignant Soft Tissue Tumours of Childhood | Phase 3 | terminated | Sep 13, 2005 | Gustave Roussy, Cancer Campus, Grand Paris | not stated | Not stated |
| NCT00160992 | Adoptive Cell Transfer Combined With Peptide Vaccination in Transiently Immunosuppressed… | Phase 1 | suspended | Sep 12, 2005 | University of Lausanne Hospitals | not stated | Not stated |
| NCT00083473 | A Pilot Study of Pivanex in Patients With Chronic Lymphocytic Leukemia | Phase 2 | terminated | May 26, 2004 | Titan Pharmaceuticals | not stated | Not stated |
| NCT00087477 | A Pilot Study of Pivanex in Patients With Malignant Melanoma | Phase 1 / Phase 2 | terminated | Jul 13, 2004 | Titan Pharmaceuticals | not stated | Not stated |
| NCT00127595 | Oxaliplatin With Gemcitabine in Patients With Carcinoma of the Urothelial Tract | Phase 2 | terminated | Aug 8, 2005 | Gustave Roussy, Cancer Campus, Grand Paris | not stated | Not stated |
| NCT00126243 | Efficacy of Rituximab and Cyclophosphamide, Doxorubicin, Vincristine, Prednisone (CHOP)… | Phase 2 | terminated | Aug 3, 2005 | French National Agency for Research on AIDS and Viral Hepatitis | not stated | Not stated |
| NCT00023166 | Phase I Study of PEG-Paclitaxel In Patients With Advanced Solid Tumors & Lymphomas | Phase 1 | terminated | Aug 27, 2001 | Enzon Pharmaceuticals, Inc. | not stated | Not stated |
| NCT00034333 | Safety and Efficacy of Doxorubicin Adsorbed to Magnetic Beads Vs. IV Doxorubicin in… | Phase 2 / Phase 3 | terminated | Apr 26, 2002 | FeRx | not stated | Not stated |
| NCT00042497 | Immunotherapy With Autologous Dexosomes for Patients With Stage IV Melanoma | Phase 2 | suspended | Aug 1, 2002 | Anosys | not stated | Not stated |
| NCT00043459 | Study of T900607-Sodium in Previously Treated Patients With Non-Hodgkin's Lymphoma. | Phase 2 | terminated | Aug 12, 2002 | Tularik | not stated | Not stated |
| NCT00048529 | Study of T900607-Sodium in Subjects With Previously Treated Gastric Cancer or… | Phase 2 | suspended | Nov 4, 2002 | Tularik | not stated | Not stated |
| NCT00057382 | T138067 Versus Doxorubicin in Chemotherapy-Naive, Unresectable, Hepatocellular Carcinoma… | Phase 2 / Phase 3 | terminated | Apr 2, 2003 | Tularik | not stated | Not stated |
| NCT00064636 | Phase I Dose Escalation Study of VELCADE Plus Docetaxel in Patients With Advanced… | Phase 1 | terminated | Jul 11, 2003 | Millennium Pharmaceuticals, Inc. | not stated | Not stated |
Stop reasons are registrant-reported free text and are displayed verbatim (truncated; hover for the full text). Categories come from explicit keyword rules and are never inferred from the study design, sponsor or outcome; a study that stopped for several reasons is filed under the first rule that matched. A TERMINATED status does not imply a negative result.
Data updated 22 days agoSource updated Sep 11, 2006source: clinicaltrials